We advised AstraZeneca, a global research-based biopharmaceutical company in relation to the company’s participation in a novel public-private partnership to improve lung cancer patient pathway in cooperation and thus contribute jointly to the implementation of the national cancer control plan. New approach National cancer control plan until year 2030 highlights the problem that cancer patients’ […]
On a pro bono basis through our 2022 Shared Mission program, we assisted the green-tech startup Filaret on various legal issues concerning their daily operations. Filaret collects and upcycles cigarette butt waste into a sustainable, compostable and nature-friendly 3D printing filament. Innovative approach Filaret organises the collection of cigarette butt waste by renting and selling […]
We advised Acton Partners, a leading venture capital fund in its investment in Estonian startup Qualitista, which uses the Klaus brand. Klaus manages a customer service quality assurance SaaS solution that aims to monitor and improve the level of customer service for small and medium-sized businesses. Series A funding Klaus raised €12M a Series A […]
In cooperation with patent bureau Käosaar, we advised and represented the Estonian political party Eesti 200 (meaning Estonia 200) in a landmark trademark dispute with non-profit organization Eesti Kultuur 200 and its leader Kärt Summatavet. Registration of word mark opposed Following the launch of the political party Eesti 200 back in 2018, Summatavet and Eesti […]
We advised Portage Ventures, leader of the investment round joined by existing investors Blackfin Capital Partners and Karma Ventures, on a EUR 15 million investment into Tuum, a Tallinn-based fintech. Strengthening EU and UK presence The round will enable the core banking technology provider – formerly known as Modularbank – to continue investing in product […]